Home / Featured Companies / Gilead Sciences Historical Data

Gilead Sciences (GILD) Financials

Gilead Sciences (GILD) Historical Financial Statements and Key Metrics for 1992 - 2020

Full Gilead Sciences financials for 1992 - 2020 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Gilead Sciences Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2020-Dec-31 7,421 6,023 (81.2 %) 2,651 (35.7 %) 1,517 (20.4 %) 1,886 1.21
2020-Sep-30 6,577 5,436 (82.7 %) 2,001 (12.5 %) 360 (5.5 %) 1,416 0.29
2020-Jun-30 5,143 4,079 (79.3 %) -2,983 (-58.0 %) -3,339 (-64.9 %) -2,377 -2.66
2020-Mar-31 5,548 4,579 (82.5 %) 2,402 (43.3 %) 1,551 (28.0 %) 2,606 1.22
2019-Dec-31 5,879 4,196 (71.4 %) 1,093 (18.6 %) 2,696 (45.9 %) 2,501 2.12
2019-Sep-30 5,604 4,569 (81.5 %) -1,473 (-26.3 %) -1,165 (-20.8 %) -901 -0.92
2019-Jun-30 5,685 4,685 (82.4 %) 2,430 (42.7 %) 1,880 (33.1 %) 3,011 1.47
Full historical income statements for 1992 - 2020 is included in the US Historical Financials dataset.

Gilead Sciences Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2020-Dec-31 68,407 50,205 31,402 18,202 7,408
2020-Sep-30 60,878 43,407 29,290 17,445 23,975
2020-Jun-30 55,934 37,907 24,102 18,027 18,914
2020-Mar-31 59,741 37,674 24,097 22,067 20,785
2019-Dec-31 61,627 39,102 24,593 22,525 24,352
2019-Sep-30 59,146 38,542 24,588 20,604 22,856
2019-Jun-30 63,210 40,594 26,083 22,616 27,183
Full historical balance sheet data for 1992 - 2020 is included in the US Historical Financials dataset.

Gilead Sciences Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2020-Dec-31 1,916 -14,615 770 2,385
2020-Sep-30 2,250 0 0 2,095
2020-Jun-30 2,566 -5,023 -874 2,423
2020-Mar-31 1,436 -344 -2,611 1,265
2019-Dec-31 2,580 431 -896 2,377
2019-Sep-30 2,645 -1,841 -2,515 2,445
2019-Jun-30 2,342 -6,163 -1,857 2,157
Full historical cash flow data for 1992 - 2020 is included in the US Historical Financials dataset.

Gilead Sciences Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2020-Dec-31 73,116 98,521 9.85 48.20 4.02
2020-Sep-30 79,303 105,298 12.06 220.29 4.55
2020-Jun-30 96,560 110,917 18.77 -28.92 5.36
2020-Mar-31 94,108 106,155 16.96 60.68 4.26
2019-Dec-31 81,297 91,760 13.83 30.15 3.61
2019-Sep-30 78,127 90,743 13.94 -67.06 3.79
2019-Jun-30 83,492 96,336 14.69 44.41 3.69
Full historical valuation and operating metrics for 1992 - 2020 are included in the US Historical Financials dataset.